Pyramid Biosciences
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of PBI-200 With Ritonavir or Cobicistat in Healthy Volunteers (NCT05692570) | Pyramid Biosciences | 2022-09-09 |
| A Phase 1 Study of the Absorption, Metabolism, and Excretion of [14C] PBI-200 (NCT05238337) | Pyramid Biosciences | 2022-02-24 |
| A Formulation Bridging and Food Effect Study of PBI-200 in Healthy Volunteers (NCT05690932) | Pyramid Biosciences | 2022-02-24 |
| A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream (NCT05514353) | Pyramid Biosciences | 2021-12-28 |
| A Study to Assess the Effect of Food on the Absorption and Bioavailability of PBI-200 (NCT05160389) | Pyramid Biosciences | 2021-11-17 |
| Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors (NCT04901806) | Pyramid Biosciences | 2021-07-20 |
| A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants (NCT04882631) | Pyramid Biosciences | 2021-04-12 |
Track Pyramid Biosciences automatically
Every clearance here is in the API, with alerts when new ones post.